Q&A with Seth Karol, MD: Risk Factors for Bone Toxicity for Patients with ALL

DECEMBER 05, 2015
Amy Jacob

Seth Karol, MD, St. Jude's Children's Research Center discussed several ways in which he and his colleagues intensified therapy over the years and referred to a key toxicity that had emerged from the two drugs they used.
Karol understands further studies are necessary to ensure their methods of reducing risks don't affect the success of curing diseases.

Copyright© MD Magazine 2006-2018 Intellisphere, LLC. All Rights Reserved.